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Abstract
Background: Traditional tuberculosis (TB) treatment outcome measures, such as cure rate, do not provide insight
into the underlying reasons for missing clinical targets. We evaluated a TB Process-Based Performance Review (TB-
PBPR) tool, developed to identify “missed opportunities” for timely and accurate diagnosis of TB. The tool enables
performance assessment at the level of process and quality of care.
Methods: The TB-PBPR tool is a single-page structured flow-sheet that identifies 14 clinical actions (grouped into
elicited symptoms, clinical examination and investigations). Medical records from selected deceased patients were
reviewed at two South African mine hospitals (A = 56 cases; B = 26 cases), a South African teaching hospital (C =
20 cases) and a UK teaching hospital (D = 13 cases).
Results: In hospital A, where autopsy was routine, TB was missed in life in 52% (23/44) of cases and was wrongly
attributed as the cause of death in 16% (18/110). Clinical omissions were identified at each hospital and at every
stage of clinical management. For example, recording of chest symptoms was omitted in up to 39% of cases,
sputum smear examination in up to 85% and chest radiograph in up to 38% of cases respectively.
Conclusions: This study introduces the TB-PBPR tool as a novel method to review and evaluate clinical
performance in TB management. We found that simple clinical actions were omitted in many cases. The tool, in
conjunction with a manual describing best practice, is adaptable to a range of settings, is educational and enables
detailed feedback within a TB programme. The TB-PBPR tool and manual are both freely available for general use.
Background
The primary aims of tuberculosis (TB) control pro-
grammes are early diagnosis and prompt treatment of
infectious cases to limit transmission [1]. To this end,
the World Health Organisation (WHO) has developed
specific outcome measures to evaluate TB control.
Hence, treatment outcomes are recorded internationally
and targets of 70% case detection and 85% cure in
smear positive pulmonary TB have been set [2]. How-
ever, these broad outcome measures do not provide
detailed insight into the pathways of clinical care or
identify reasons for missing the targets.
Methods of TB diagnosis have not changed signifi-
cantly for many decades; resting primarily on clinical
history, clinical examination, chest radiograph (CXR),
and sputum smear and culture. Despite this long experi-
ence, there is overwhelming evidence from studies pub-
lished over the last 50 years that TB diagnosis is prone
to significant error [3-9]. Misdiagnosis occurs both if TB
is missed and if TB is over-diagnosed. For example, a
recent South African study found 21% of adults dying in
hospital with a pre-mortem diagnosis of “TB” had no
TB at autopsy [10], while in Italy in 1996, 36% of
deceased AIDS patients with clinical diagnoses of TB
had no evidence of TB at autopsy [11]. On the other
hand, and of more concern to public health, are studies
from the USA that suggest 5% of notified TB cases are
diagnosed only after death [12,13], plus several large
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autopsy studies showing that TB is missed in life in
18-54% of cases with pathological evidence of active TB
[9,14-16]. Avoidable clinical errors can contribute to
delays or error in TB diagnosis [17].
This study describes a novel method for evaluating TB
control at the point of care using a Process-Based Per-
formance Review tool (TB-PBPR) to identify missed
opportunities for early and accurate TB diagnosis. PBPR
is a teaching strategy where clinicians retrospectively
review patient records to evaluate crucial clinical
actions, and has been shown to improve clinical perfor-
mance [18,19]. Following initial development and pilot-
ing in the South African mining industry [20,21], we
evaluated the tool by applying it to identify missed
opportunities in deceased patients in four different hos-
pital settings.
Methods
The TB-PBPR tool consists of a single-page structured
flow sheet (see additional file 1). Each element is derived
from clinical evidence and, as a whole, is in accordance
with the 2006 International Standards for TB Care
(ISTC) [22]. A manual containing concise, evidence-
based clinical summaries was developed for use in con-
junction with the TB-PBPR tool to provide guidance on
best practice [23].
Recorded data include demographics, clinical and
autopsy diagnoses, important clinical actions, missed
opportunities and response to therapy. The tool evalu-
ates the integrated process of care for a number of
essential clinical actions; first through identification of
whether each clinical action was performed, and second
through assessment of whether the result of that clinical
action was recorded and then acted on appropriately.
In total, the TB-PBPR tool identifies 14 clinical actions
which, if carried out, should minimize the number of
missed diagnoses: eliciting TB symptoms constitutes 1,
clinical examination 6 and clinical investigations 7.
“Missed opportunities” are identified as errors causing
potential failure to make timely and accurate clinical
diagnoses. For example, with regard to CXR, a missed
opportunity would be identified if a CXR were omitted,
if a CXR were performed but the result not obtained, or
if the result were obtained but not acted upon. Where
no documentation is found in the clinical notes, the
action is recorded as omitted. The tool takes account of
the circumstances in which different investigations are
indicated because certain investigations may not be
required in every patient. For example, lymph node
aspiration is not applicable in the absence of lymphade-
nopathy. When sputum examination identifies TB,
further investigations to identify TB are recorded ‘not
applicable’.
The TB-PBPR tool evaluates a group of ‘other’ investi-
gations, which should be considered in accordance with
ISTC guideline 3 (to investigate extrapulmonary TB),
particularly in HIV positive cases with suspected TB and
three negative sputum smears [22].
We evaluated the TB-PBPR tool in four hospitals (two
South African platinum mine hospitals and two tertiary-
care teaching hospitals (one in South Africa and one in
the UK)). Cases were selected using different criteria
(outlined below) to assess the tool’s use in a range of
healthcare settings, patient groups and populations. The
TB rate is close to 1000 per 100,000 in the general
South African population [24], and estimated adult HIV
prevalence is 18% [25]. Although TB is less common in
the UK than South Africa, the UK-based hospital serves
the London community where TB rates (43 per 100,000)
are much higher than elsewhere in the country [26].
A medical doctor completed each TB-PBPR flow sheet
using the accompanying manual in ~40 minutes.
Hospital A (South African platinum mine hospital 1)
In this setting, autopsies are conducted for compensa-
tion purposes in terms of the Occupational Diseases in
Mines and Works Act (ODMWA). Provided next of kin
give consent, autopsy is performed in all men dying in
employment regardless of the clinical cause of death.
Cases not submitted are generally those who die off
mine premises. Deceased miners’ heart and lungs are
removed at their place of employment, placed in forma-
lin and dispatched to the South African National
Institute for Occupational Health (NIOH), where histo-
pathology is performed according to a standardized
protocol [27,28]. Pathological TB is diagnosed in the
presence of necrotizing granulomatous inflammation
and/or presence of acid-fast bacilli, other causes having
been excluded. Results are stored in the PATHAUT
computerised database [29,30].
All patients from hospital A who died and had an
autopsy of cardio-respiratory organs at the NIOH
between October 2006 and December 2007 (n = 110)
were considered for this study. The subset with a clini-
cal and/or autopsy diagnosis of pulmonary TB (n = 62)
were selected for review using the TB-PBPR tool. Clini-
cal notes were available for 56 cases.
Hospital B (South African platinum mine hospital 2)
No autopsies were performed for hospital B. Therefore,
all patients who died during 2007 (n = 60) were consid-
ered for this study. The subset of those with a natural
cause of death were selected for review (n = 35). Clinical
notes were available for 26 cases. TB diagnosis was
taken from clinical records and made on clinical or
microbiological grounds.
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A health care service, comprising primary care clinics,
specialised clinics and hospital facilities, is provided free
of charge to all mine employees at hospitals A and B,
approximately 18,000 workers in each case. The health-
care services run their own TB control programmes.
Hospital C (2700-bed public sector South African tertiary-
care teaching hospital)
A convenience sample of 20 deceased individuals with a
pre-mortem clinical diagnosis of TB and undergoing
autopsy during the period December 2003 to March
2005 at Chris Hani Baragwanath Hospital (CHBH),
Soweto as described by Martinson et al [10] was
selected for review. Eligibility criteria for the original
study included: >18 years of age, survival in hospital for
>24 h and next of kin consenting to a full autopsy.
Hospital D (1000-bed public sector UK tertiary-care
teaching hospital)
No autopsy data were available for hospital D. Therefore
all patients who were registered with the TB programme
at the Royal Free Hospital (RFH), London, and who died
between January 2004 and December 2007 (n = 22) were
considered for this study. Clinical notes were available
for 13 cases, who did not differ significantly in age, sex or
ethnicity from cases for whom notes were unavailable.
Ethical approval was obtained from the University of
the Witwatersrand. Work in the UK hospital was under-
taken as part of a clinical audit of TB services and,
therefore, no local ethical approval was required.
Results
Patients
We reviewed medical records from 115 patients who
died at the four hospitals using the TB-PBPR tool
(Table 1). The duration of hospital admission was >24 h
in 96% (110/115) of patients. Most patients at the South
African hospitals (80-96%) were known to have HIV
infection and in the mining hospitals, many had pre-
viously been treated for TB. The proportion treated for
TB at final admission varied according to hospital
setting (57-92%), with treatment started empirically
(without microbiological evidence) in 25-53% of cases.
Clinico-Pathological Comparison
During the study period, 214 deaths were recorded at
Hospital A. Autopsy was performed on 110 cases, in
whom active TB was found in 40% (44/110). TB was
missed in life in 52% (23/44) of cases and was wrongly
attributed as the cause of death in 16% (18/110). The
sensitivity of clinical diagnosis for TB was 48% (21/44)
and specificity 73% (48/66) when measured against
autopsy. Data on clinico-pathological comparison for
Hospital C cases are published elsewhere [10].
Symptoms and Clinical Examination
Eliciting of TB symptoms is evaluated by the TB-PBPR
tool on the basis of whether 3 symptoms are recorded.
Importantly, the tool cannot distinguish between omis-
sions of clinical action and omissions of clinical record.
Depending on the hospital, symptoms of chest complaint
(cough/haemoptysis/pain) were omitted in up to 39% of
patients, weight loss between 15% and 73%, and fever/
night sweats in up to 81% (Table 2). The TB-PBPR tool
evaluates clinical examination on the basis of 6 clinical
actions (Table 2). Chest auscultation was omitted in 32%
and 50% of patients from mine hospital A and B respec-
tively, but always performed at both teaching hospitals.
Examination for weight loss and lymphadenopathy were
performed poorly at all four hospitals, being omitted in
31% to 85% of patients. Notwithstanding clinical omis-
sions, at least one positive clinical finding was documen-
ted for most patients: 93% (52/56) at hospital A, 88% (23/
26) at hospital B and 100% at both hospital C and D.
Investigations
Following symptoms and clinical examination, the tool
assesses whether clinical investigations were performed
appropriately (Table 3). Investigations were omitted in hos-
pitals A to C as follows; CXR in up to 38%; sputum smear
in up to 85%; sputum culture in up to 90% (Table 3). How-
ever, in hospital D, these investigations were performed in
Table 1 Characteristics of cases by hospital
Hospital A (n = 56) Hospital B (n = 26) Hospital C (n = 20) Hospital D (n = 13)
Country, hospital type SA, mining SA, mining SA, teaching UK, teaching
% male 100 100 48 60
Age/y; median (range) 48 (26-64) 43 (20-64) 37 (22-61) 46 (24-69)
Duration of admission/days; median (range) 11 (1-110) 7 (1-67) 5 (3-32) 38 (7-85)
TB treatment completed previously; n (%) 26 (46) 10 (39) 3 (10) 0 (0)
†HIV-infected; n (%) 54 (96) 23 (89) 16 (80) 5 (39)
TB treated at final admission; n (%) 32 (57) 16 (62) 14 (70) 12 (92)
Empirical TB treatment; n (%) 17 (53) 4 (25) 6 (43) 3 (25)
† HIV status was unknown in 2, 1, 3 and 1 cases in Hospitals A-D respectively.
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every case. Assessment of other investigations such as
lymph node aspiration, pleural tap and lumbar puncture
depends upon recording of relevant clinical details. For
example, in the absence of examination for lymphadenopa-
thy it was impossible to evaluate the use of lymph node
aspiration (marked ‘no exam’). Nonetheless, we did identify
cases in hospitals A, B and D where lymphadenopathy was
present but lymph node biopsy was omitted (Table 3).
Missed Opportunities
For each of the 14 clinical actions, the tool collapses the
chain of clinical process to identify a missed opportunity
where the process failed. For eliciting of TB symptoms,
the clinical process was considered complete provided
one or more symptoms were recorded and appropriate
investigations had been performed. We found a mean of
8.8, 9.8, 7.2 and 2.4 missed opportunities per patient at
hospitals A-D respectively (Figure 1). For both mine
hospitals, we were able to review attendances to the
hospital or outpatient clinics in the 3 months before
final admission as a surrogate measure of opportunities
for earlier intervention. In hospital A, 86% (47/56) of
patients had attended at least once while the proportion
in hospital B was 92% (24/26). The median number of
attendances was 3 and 7 respectively.
Discussion and Conclusions
We applied a TB-Process Based Performance Review
tool as a novel method to evaluate accurate and timely
diagnosis of TB. We evaluated the tool in deceased
Table 2 Clinical actions: eliciting of clinical symptoms and examination (%)
Hospital A (n = 56) Hospital B (n = 26) Hospital C (n = 20) Hospital D (n = 13)
Omitted Action
performed
Omitted Action
performed
Omitted Action
performed
Omitted Action
performed
Absent Present Absent Present Absent Present Absent Present
Symptoms elicited
Chest complaint 38 7 55 39 0 62 15 5 80 0 39 62
Weight loss 63 5 32 73 0 27 55 0 45 15 8 77
Fever/night sweats 46 9 44 81 0 19 60 5 35 0 54 46
Examination
Chest auscultation
abnormal
32 20 48 50 19 31 0 15 85 0 46 54
Evidence of weight
loss
63 0 38 69 0 31 35 0 65 85 0 15
Pleural effusion 39 52 9 96 0 4 80 5 15 39 31 31
Lymphadenopathy 86 5 9 89 12 0 40 45 15 31 23 46
Hepatosplenomegaly 59 27 14 84 15 0 25 35 40 0 31 69
Neck stiffness/
confusion
71 23 5 73 12 15 45 35 20 15 62 23
The TB-PBPR tool was used to evaluate medical records to determine whether clinical actions were omitted or performed. Where an action was performed, we
recorded whether symptoms and examination findings were absent or present. For example, in hospital A, clinicians omitted eliciting symptoms of chest
complaint (cough/haemoptysis/pain) in 38% of patients. Chest symptoms were elicited in the remaining patients (Action performed); these symptoms were
absent in 7% and present in 55% of patients.
Table 3 Clinical actions: use of appropriate investigations (%)
Hospital A (n = 56) Hospital B (n = 26) Hospital C (n = 20) Hospital D (n = 13)
NA No
exam
Omitted Done NA No
exam
Omitted Done NA No
exam
Omitted Done NA No
exam
Omitted Done
Chest
radiograph
0 - 38 63 0 - 35 65 0 - 35 65 0 - 0 100
Sputum Smear 0 - 52 48 4 - 42 54 10 - 85 5 15 - 0 85
Sputum
Culture
0 - 75 25 4 - 54 42 10 - 90 0 15 - 0 85
LN aspiration 11 80 9 0 23 77 0 0 45 35 15 5 69 8 15 8
Pleural tap 66 21 2 11 0 96 0 4 10 70 0 20 69 8 8 15
Lumbar
puncture
54 25 2 20 19 62 0 19 30 40 5 25 46 15 0 39
Other 25 - 68 7 8 - 89 4 10 - 45 45 54 - 0 46
The TB-PBPR tool was used to assess whether appropriate investigations were performed. We recorded ‘NA’ where the investigation was not applicable (for
example, where ‘Sputum Smear’ had identified acid fast bacilli), we recorded ‘no exam’ where the relevant clinical examination was not documented, we
recorded ‘omitted’ where an investigation was applicable but not performed, and we recorded ‘done’ where the investigation was performed. For example, in
hospital C, lymph node (LN) aspiration was not applicable in 45% of patients and was not documented in 35% of patients. LN aspiration was omitted in 15% and
done in 5% of the patients.
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patients, where clinical management may have failed.
We therefore expected to find omissions in clinical pro-
cess, and this may not be representative of the TB pro-
grammes in their entirety. Used in conjunction with
autopsy results, as for hospitals A and C, the tool decon-
structs a patient’s clinical care to capture diagnostic
errors. In the absence of autopsy data, as for hospitals B
and D, the tool still provides valuable insight into patient
care and overall TB programme performance. Where
documentation was missing, we recorded an omission
because clear documentation is essential for clinical gov-
ernance as well as communication reasons. We found
that simple but fundamental diagnostic clinical actions
such as chest auscultation, CXR and sputum smear were
not recorded in many cases. The tool highlights specific
areas for improvement within each setting. Similar sys-
tem failures have been reported in South African urban
state clinics [31]. In the absence of a systematic clinical
history, examination, and appropriate investigation, the
evidence base for logical diagnostic decision-making is
lost. This is important in TB (particularly with HIV co-
infection) where cases can present diagnostic challenges
even where all appropriate investigations seem to have
been explored [8]. Similarly, implementation of a 19-
point checklist of simple clinical actions was associated
with significant improvements in surgical outcome [32].
Many of these 115 patients presented with symptoms
that should have prompted clinicians to consider TB
(Table 2); overall 62% presented with chest symptoms,
38% with symptoms of weight loss and 37% with fever
or night sweats. Other indications of the possibility of
TB existed in these patients, 34% had previously been
treated for TB and 85% were HIV-infected. All admitted
patients survived for at least 24 h (many survived for
longer). Clinicians therefore had opportunity to initiate
investigations and treatment, and in many cases to
monitor the response to treatment. Furthermore, in hos-
pitals A and B, we found most cases made contact with
medical services in the three months before final admis-
sion. We would expect to find further missed opportu-
nities in these earlier patient/clinician interactions.
We highlight that sputum culture results were missing
for so many of the South African patients, although this
investigation was available in all hospitals. The dangers of
multidrug resistance have been well described [33], and a
high index of suspicion must be maintained, particularly
where patients fail to improve on TB treatment or have
recurrent TB (ISTC, standard 14 [22]). On the other hand,
HIV testing was performed well, acknowledging the impor-
tance of ascertaining HIV status where TB is suspected.
Different criteria were used for selection at each hospi-
tal, with the important distinction that (in this study)
Figure 1 Histograms showing the distribution of total missed opportunities per case (maximum 14) for each hospital.
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patients at Hospitals C and D were diagnosed with TB
pre-mortem. However, a differential diagnosis that
included TB was common to all. Although the selection
criteria varied, and this limits comparison, the four hospi-
tals do allow some useful broad observations to be made.
We demonstrate that the tool identifies missed opportu-
nities in a variety of settings, both in public and private
hospitals, and in developed and developing countries. We
recognise that not all missed opportunities carry equal
weight but found the total number of missed opportunities
to be a useful assessment of overall performance. The
findings in hospital D, although the number of patients
was small, suggest that it may be possible to achieve low
numbers of missed opportunities for some patient groups,
and this supports previous data showing that, despite low
rates of error, some deaths are unavoidable [17]. Omis-
sions in clinical care occur throughout the world and are
not limited to TB; one study found that 45% of US adults
do not receive care that is consistent with current recom-
mendations [34]. If simple clinical actions are omitted in
these settings, where TB prevalence is high, this raises
concerns about settings where clinicians have far less
experience of treating TB.
The TB-PBPR tool was designed and used here for in-
patients and may require adaptation before use in some
low income outpatient settings where clinical records
may be less detailed. However, many of the key missed
opportunities such as basic history taking and sputum
smear are common to nearly all settings. Further evalua-
tion will assess whether the TB-PBPR tool can be used
to improve local clinical and programme management.
Successful TB control requires basic clinical and pub-
lic health management to be performed efficiently and
consistently. Clinical omissions and misdiagnoses have
implications for both the individual and the community,
delaying treatment and increasing the period of infectiv-
ity leading to increased transmission, treatment failure,
medical costs, and deaths.
The tool was designed with an educational objective in
mind, to be used by clinicians to reflect on clinical prac-
tice and monitor missed opportunities. The TB-PBPR
tool may be particularly useful to improve clinical care
in patients with a range of poor outcomes, (e.g, develop-
ment of drug resistance and recurrence) and its use is
not limited to deceased patients. We suggest that the
tool may augment broader WHO measures for TB pro-
grammes because it allows detailed evaluation to feed-
back into a TB programme and improve clinical care.
Additional material
Additional file 1: The TB-PBPR tool.
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